Global beauty company APR is making bold moves to expand its successful home beauty device business into the professional medical equipment sector.
According to South Korea’s Financial Supervisory Service’s electronic disclosure system on Wednesday, APR will hold its 12th annual shareholders’ meeting on March 31 to propose amendments to its articles of incorporation, adding new business objectives.
The proposed additions include the development, manufacturing, and sales of medical devices and consumables, medical supplies, as well as medical device repair services.
This strategic move aims to clearly define the scope of APR’s long-term initiative in the specialized medical device sector and proactively establish the necessary infrastructure for future product launches.
During a recent earnings call on February 4, APR revealed plans to obtain regulatory approval for the development of injectable Class 4 medical devices and commence domestic production.
APR has built a strong market position and amassed global regulatory and development expertise through its home beauty brand, MediCube AGE-R.
By leveraging these technical assets in the specialized medical device market, APR aims to create a comprehensive beauty tech portfolio that encompasses professional care solutions.
Currently, APR is in the process of establishing a manufacturing facility for medical devices and pursuing relevant certifications. The company has stated that it cannot disclose specific details about the progress of preclinical and clinical studies at this time.
An APR spokesperson explained that the addition of these business objectives is a comprehensive measure to establish a regulatory foundation for the future medical device operations. This should be understood as a step aligning with the long-term strategic direction rather than an immediate launch of specific new business activities.